Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene

被引:42
作者
Gunn, Shelly R. [1 ,2 ]
Bolla, Aswani R. [1 ]
Barron, Lynn L. [3 ]
Gorre, Mercedes E. [2 ]
Mohammed, Mansoor S. [2 ]
Bahler, David W. [6 ,7 ]
Mellink, Clemens H. M. [8 ]
van Oers, Marinus H. J. [9 ]
Keating, Michael J. [4 ]
Ferrajoli, Alessandra [4 ]
Coombes, Kevin R. [5 ]
Abruzzo, Lynne V. [3 ]
Robetorye, Ryan S. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX USA
[2] Combimatrix Mol Diagnost Inc, Irvine, CA USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[6] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[7] Univ Utah, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
[8] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands
[9] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands
关键词
Chronic lymphocytic leukemia; Array CGH; Chromosome; 22q11; PRAME gene; ANTIGEN; EXPRESSION; MELANOMA; DISORDERS;
D O I
10.1016/j.leukres.2008.10.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We used BAC array-based CGH to detect genomic imbalances in 187 CLL cases. Submicroscopic deletions of chromosome 22q11 were observed in 28 cases (15%), and the frequency of these deletions was second only to loss of the 13q14 region, the most common genomic aberration in CLL Oligonucleotide-based array CGH analysis showed that the 22q11 deletions ranged in size from 0.34 Mb up to similar to 1 Mb. The minimally deleted region included the ZNF280A, ZNF280B, GGTLC2, and PRAME genes. Quantitative real-time PCR revealed that ZNF280A, ZNF280B, and PRAME mRNA expression was significantly lower in the 22q11 deletion cases compared to non-deleted cases. Published by Elsevier Ltd.
引用
收藏
页码:1276 / 1281
页数:6
相关论文
共 24 条
  • [1] Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner, H
    Stilgenbauer, S
    Benner, A
    Leupolt, E
    Kröber, A
    Bullinger, L
    Döhner, K
    Bentz, M
    Lichter, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) : 1910 - 1916
  • [2] Prevalence and prognostic and predictive relevance of PRAME in breast cancer
    Doolan, Padraig
    Clynes, Martin
    Kennedy, Susan
    Mehta, Jai Prakash
    Crown, John
    O'Driscoll, Lorraine
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) : 359 - 365
  • [3] A common molecular basis for rearrangement disorders on chromosome 22q11
    Edelmann, L
    Pandita, RK
    Spiteri, E
    Funke, B
    Goldberg, R
    Palanisamy, N
    Chaganti, RSK
    Magenis, E
    Shprintzen, RJ
    Morrow, BE
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (07) : 1157 - 1167
  • [4] PRAME expression and clinical outcome of breast cancer
    Epping, M. T.
    Hart, A. A. M.
    Glas, A. M.
    Krijgsman, O.
    Bernards, R.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 398 - 403
  • [5] The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
    Epping, MT
    Wang, LM
    Edel, MJ
    Carlée, L
    Hernandez, M
    Bernards, R
    [J]. CELL, 2005, 122 (06) : 835 - 847
  • [6] Childhood acute myelogenous leukaemia:: Association between PRAME, apoptosis- and MDR-related gene expression
    Goellner, Stefanie
    Steinbach, Daniel
    Schenk, Tino
    Gruhn, Bernd
    Zintl, Felix
    Ramsay, Edward
    Saluz, Hans P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (16) : 2807 - 2814
  • [7] Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia
    Gunn, Shelly R.
    Mohammed, Mansoor S.
    Gorre, Mercedes E.
    Cotter, Philip D.
    Kim, Jaeweon
    Bahler, David W.
    Preobrazhensky, Sergey N.
    Higgins, Russell A.
    Bolla, Aswani R.
    Ismail, Sahar H.
    de Jong, Daphne
    Eldering, Eric
    van Oers, Marinus H. J.
    Mellink, Clemens H. M.
    Keating, Michael J.
    Schlette, Ellen J.
    Abruzzo, Lynne V.
    Robetorye, Ryan S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (05) : 442 - 451
  • [8] Gunn Shelly R, 2008, Expert Opin Med Diagn, V2, P731, DOI 10.1517/17530059.2.6.731
  • [9] Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
    Ikeda, H
    Lethe, B
    Lehmann, F
    VanBaren, N
    Baurain, JF
    DeSmet, C
    Chambost, H
    Vitale, M
    Moretta, A
    Boon, T
    Coulie, PG
    [J]. IMMUNITY, 1997, 6 (02) : 199 - 208
  • [10] Genomic disorders on 22q11
    McDermid, HE
    Morrow, BE
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (05) : 1077 - 1088